MDR1 T-129C polymorphism can be predictive of differentiation, and thereby prognosis of colorectal adenocarcinomas in Japanese

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 7, 2006, Pages 1449-1453

  Koyama, Tatsuya ^a   Nakamura, Tsutomu ^b   Komoto, Chiho ^b   Sakaeda, Toshiyuki ^a,b   Taniguchi, Mayuko ^a   Okamura, Noboru ^a   Tamura, Takao ^a   Aoyama, Nobuo ^b   Kamigaki, Takashi ^a   Kuroda, Yoshikazu ^a   Kasuga, Masato ^a   Kadoyama, Keiichi ^c   Okumura, Katsuhiko ^a,b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal adenocarcinoma; Differentiation; Expression; Genetic polymorphism; MDR1

Indexed keywords

BUTYRIC ACID; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; RETINOIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; TISSUE DIFFERENTIATION; TUMOR BIOPSY; UPREGULATION;

ADENOCARCINOMA; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; CYTOSINE; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; GENOTYPE; HUMANS; JAPAN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THYMINE;

EID: 33745728026     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1449     Document Type: Article

References (38)

1. Sakaeda T., Nakamura T., Okumura K., Biol. Pharm. Bull., 25, 1391-1400 (2002).
2. Sakaeda T., Nakamura T., Okumura K., Pharmacogenomics, 4, 397-410 (2003).
3. Sakaeda T., Nakamura T., Okumura K., Curr. Top. Med. Chem., 4, 1385-1398 (2004).
4. Okamura N., Sakaeda T., Okumura K., Personalized Med., 1, 85-104 (2004).
5. Sakaeda T., Drug Metab. Pharmacokinet., 20, 391-414 (2005).
6. Juliano R. L., Ling V., Biochim. Biophys. Acta, 455, 152-162 (1976).
7. Chen C., Chin J. E., Ueda K., Clark D. P., Pastan I., Gottesman M. M., Roninson I. B., Cell, 47, 381-389 (1986).
8. Roninson I. B., Chin J. E., Choi K. G., Gros P., Housman D. E., Fojo A., Shen D. W., Gottesman M. M., Pastan I., Proc. Natl. Acad. Sci. U.S.A., 83, 4538-4542 (1986).
9. Takara K., Sakaeda T., Okumura K., Curr. Pharm. Design, 12, 273-286 (2006).
10. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C., Proc. Natl. Acad. Sci. U.S.A., 84, 7735-7738 (1987).
11. Johnstone R. W., Ruefli A. A., Smyth M. J., Trends Biochem. Sci., 25, 1-6 (2000).
12. Johnstone R. W., Ruefli A. A., Tainton K. M., Smyth M. J., Leukemia Lymphoma, 38, 1-11 (2000).
13. Chaudhary P. M., Roninson I. B., Cell, 66, 85-94 (1991).
14. Ismail T., Hallissey M. T., Fielding J. W., World J. Surg., 19, 178-183 (1995).
15. Sugao Y., Yao T., Kubo C., Tsuneyoshi M., Histopathology, 31, 123-133 (1997).
16. Takeuchi K., Kuwano H., Tsuzuki Y., Ando T., Sekihara M., Hara T., Asao T., Hepatogastroenterology, 51, 1698-1702 (2004).
17. van Belzen N., Dinjens W. N., Eussen B. H., Bosman F. T., Histol. Histopathol., 13, 1233-1242 (1998).
18. Sakaeda T., Nakamura T., Horinouchi M., Kakumoto M., Ohmoto N., Sakai T., Morita Y., Tamura T., Aoyama N., Hirai M., Kasuga M., Okumura K., Pharm. Res., 18, 1400-1404 (2001).
19. Horinouchi M., Sakaeda T., Nakamura T., Morita Y., Tamura T., Aoyama N., Kasuga M., Okumura K., Pharm. Res., 19, 1581-1585
20. Nakamura T., Sakaeda T., Horinouchi M., Tamura T., Aoyama N., Shirakawa T., Matsuo M., Kasuga M., Okumura K., Clin. Pharmacol. Ther., 71, 297-303 (2002).
21. Moriya Y., Nakamura N., Horinouchi M., Sakaeda T., Tamura T., Aoyama N., Shirakawa T., Gotoh A., Fujimoto S., Matsuo M., Kasuga M., Okumura K., Biol. Pharm. Bull., 25, 1356-1359 (2002).
22. Nakamura T., Sakaeda T., Ohmoto N., Tamura T., Aoyama N., Shirakawa T., Kamigaki T., Nakamura T., Kim K. I., Kim S. R., Kuroda Y., Matsuo M., Kasuga M., Okumura K., Drug Metab. Dispos., 30, 4-6 (2002).
23. Sakaeda T., Nakamura T., Hirai M., Kimura T., Wada A., Yagami T., Kobayashi H., Nagata S., Okamura N., Yoshikawa T., Shirakawa T., Gotoh A., Matsuo M., Okumura K., Pharm. Res., 19, 1323-1329 (2002).
24. Moriya Y., Nakamura T., Okamura N., Sakaeda T., Horinouchi M., Tamura T., Aoyama N., Kasuga M., Okumura K., Biol. Pharm. Bull., 29, 535-538 (2006).
25. Smyth M. J., Krasovskis E., Sutton V. R., Johnstone R. W., Proc. Natl. Acad. Sci. U.S.A., 95, 7024-7029 (1998).
26. Johnstone R. W., Cretney E., Smyth M. J., Blood, 93, 1075-1085 (1999).
27. Goto M., Masuda S., Saito H., Inui K., Biochem. Pharmacol., 66, 163-170 (2003).
28. Oudard S., Levalois C., Andrieu J.-M., Bougaran J., Validire P., Thiounn N., Poupon M.-F., Fourme E., Chevillard S., Anticancer Res., 22, 121-128 (2002).
29. Hinoshita E., Uchiumi T., Taguchi K., Kinukawa N., Tsuneyoshi M., Maehara Y., Sugimachi K., Kuwano M., Clin. Cancer Res., 6, 2401-2407 (2000).
30. Arnal M., Franco N., Fargeot P., Riedinger J. M., Brunet-Lecomte P., Lizard-Nacol S., Breast Cancer Res. Treat., 61, 13-20 (2000).
31. Potocnik U., Ravnik-Glavac M., Golouh R., Glavac D., J. Med. Genet., 39, 340-346 (2002).
32. Purdie C. A., Piris J., Histopathology, 36, 121-126 (2000).
33. Chung C. K., Zaino R. J., Stryker J. A., J. Surg. Oncol., 21, 143-148 (1982).
34. Stromskaya T. P., Rybalkina E. Y., Zabotina T. N., Shishkin A. A., Stavrovskaya A. A., Cancer Cell Int., 5, 15 (2005).
35. Tokura Y., Shikami M., Miwa H., Watarai M., Sugamura K., Wakabayashi M., Satoh A., Imamura A., Mihara H., Katoh Y., Kita K., Nitta M., Leuk. Res., 26, 29-36 (2002).
36. Frommel T. O., Coon J. S., Tsuruo T., Roninson I. B., Int. J. Cancer, 55, 297-302 (1993).
37. Takeshita A., Shigeno K., Shinjo K., Naito K., Ohnishi K., Hayashi H., Tanimoto M., Ohno R., Leuk. Lymphoma., 42, 739-746 (2001).
38. Tanabe M., Ieiri I., Nagata N., Inoue K., Ito S., Kanamori Y., Takahashi M., Kurata Y., Kigawa J., Higuchi S., Terakawa N., Otsubo K., J. Pharmacol. Exp. Ther., 297, 1137-1143 (2001).